Integration Life Sciences Pharmaceuticals Regulations 
HIT Consultant
APRIL 5, 2023
What You Should Know: Dot Compliance , a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence.
HIT Consultant
MARCH 26, 2023
While the pharmaceutical industry and life sciences are often criticized for slow technological adoption, the metaverse presents an enormous opportunity for early adoption built on a clear understanding of value. He has 25 years of tech experience, including 16 years in the life sciences industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
JULY 18, 2022
Dan UpDyke, Strategic Marketing Manager Life Sciences at Rockwell Automation. The ability to navigate constant disruption is a prerequisite for success in today’s life science industries. Mounting Challenges for Life Sciences Companies. It’s all happening in the midst of historic labor shortages.
HIT Consultant
OCTOBER 25, 2022
The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% of the companies included in the analysis recruiting for at least one such position. . Operational Challenges of AI.
HIT Consultant
DECEMBER 19, 2023
Gary Shorter – Head, AI and Data Science, IQVIA Technologies In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.
HIT Consultant
JUNE 25, 2024
However, while omnichannel is far from being simple in any industry, it raises unique challenges in the pharmaceutical industry. Some of these challenges stem from the nature of sales and marketing in pharma, where others stem from data limitations, process characteristics and regulations.
HIT Consultant
NOVEMBER 8, 2022
And given the fact that prescription drug prices continue to increase, the topic of drug price management is likely to continue to capture the attention of the media and policymakers at the state level, given the current lack of overriding federal regulation. What Can Pharmaceutical Companies Do to Stay Compliant?
Expert insights. Personalized for you.
98 
Let's personalize your content